ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bokesch, P.
Right arrow Articles by Mee, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bokesch, P.
Right arrow Articles by Mee, R.
Related Collections
Right arrow Coronary disease

Ann Thorac Surg 2002;73:S366
© 2002 The Society of Thoracic Surgeons

SUPPLEMENT: OUTCOMES 2001: SCIENTIFIC ABSTRACTS

S100ß in neonates and infants with congenital heart disease

P. Bokesch, MDa, M. Cavaglia, MDa, E. Appachi, MDa, E. Mossad, MDa, J. Tome, MDa, R. Mee, MDa

a Departments of Cardiothoracic Anesthesia and Pediatrics, Cleveland Clinic, Cleveland, Ohio, USA

Introduction. The brain-derived protein S100ß is a serum marker for brain damage. Adults with increased serum levels of S100ß (>0.5 µg/L) after cardiac surgery have strokes and adverse neurological outcomes. The purpose of this study was to measure S100ß in neonates . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The Society of Thoracic Surgeons.